Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734955 · ClinicalTrials.gov registry record · NA
An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
NCT00734955 is a NA study that has completed, run by Duke University. The registered enrollment target is 485 participants.
The verdict
NCT00734955, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
Study Summary
Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also shown that data collection and processing from a single point on the tissue specimen requires less than 5 seconds. In addition, the technique is easily adaptable to provide sensing depths that are required for breast margin assessment. The goal of the work proposed in this protocol is to test the sensitivity and specificity of an optical assay system developed by our group, for intra operative assessment of breast tumor margins.
Interventions
- DEVICE 49-channel optical spectrometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2006-05 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00734955
The ClinicalTrials.gov registry entry for NCT00734955 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 49-channel optical spectrometer is the first listed.
NCT00734955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00734955 about?
NCT00734955 is a clinical study titled "An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients". Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also...
What is the current status of trial NCT00734955?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2006-05. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00734955?
The interventions under investigation include: 49-channel optical spectrometer (DEVICE).
Who is sponsoring clinical trial NCT00734955?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.